Phathom Pharmaceuticals, Inc. (PHAT)
9.83
-0.17
(-1.70%)
USD |
NASDAQ |
Jun 09, 13:50
Phathom Pharmaceuticals EPS Diluted (Quarterly) : -0.3701 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.37M |
| Revenue (Quarterly) | 58.30M |
| Total Expenses (Quarterly) | 88.67M |
| Enterprise Value | 1.161B |
| Gross Profit Margin (Quarterly) | 79.42% |
| Profit Margin (Quarterly) | -52.09% |
| Earnings Yield | -21.48% |
| Normalized Earnings Yield | -21.48 |